LWM Advisory Services’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,077
Closed -$489K 99
2022
Q3
$489K Buy
1,077
+68
+7% +$32.5K 0.55% 54
2022
Q2
$487K Buy
1,009
+83
+9% +$41.1K 0.58% 50
2022
Q1
$455K Buy
926
+219
+31% +$100K 0.57% 51
2021
Q4
$328K Buy
+707
New +$297K 0.41% 73

Other funds holding ELV

LWM Advisory Services's ELV Position: Q4 2022 in Review

LWM Advisory Services sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 1,077 shares — an estimated $489K sold.

LWM Advisory Services first reported a position in ELV in Q4 2021 and held it in 4 quarters. The position peaked at $489K in Q3 2022. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

  • LWM Advisory Services reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
  • LWM Advisory Services sold 1,077 Elevance Health shares in Q4 2022, an estimated $489K.
  • LWM Advisory Services first reported a position in Elevance Health in Q4 2021 and held it in 4 quarters.
  • LWM Advisory Services's Elevance Health position peaked at $489K in Q3 2022.
  • 1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on LWM Advisory Services's 13F filing for Q4 2022, filed 7 Feb 2023.